Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.
Medicine
{PDF} Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research: Workshop Summary Steve Olson and Adam C. Berger; Roundtable on Translating Genomic-Based Research for Health, Institute of Medicine
$9.99
Related products
-
Engineering
[PDF] Examining Core Elements of International Research Collaboration: Summary of a Workshop Planning Committee for the Workshop on Examining Core Elements of International Collaboration, Government-University-Industry Research Roundtable, Policy and Global Affairs, National Academy of Sciences, National Academy of Engineering, Institute of Medicine, National Academies
$19.99 Order now
Reviews
There are no reviews yet.